Your browser doesn't support javascript.
loading
Therapeutic efficiency of the APAF-1 antagonist LPT99 in a rat model of cisplatin-induced hearing loss.
Murillo-Cuesta, Silvia; Celaya, Adelaida M; Cervantes, Blanca; Bermúdez-Muñoz, Jose M; Rodríguez-de la Rosa, Lourdes; Contreras, Julio; Sánchez-Pérez, Isabel; Varela-Nieto, Isabel.
Afiliación
  • Murillo-Cuesta S; Biomedical Research Networking Center on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.
  • Celaya AM; Institute for Biomedical Research "Alberto Sols", Spanish National Research Council-Autonomous University of Madrid, Spain.
  • Cervantes B; Hospital La Paz Institute for Health Research, Madrid, Spain.
  • Bermúdez-Muñoz JM; Biomedical Research Networking Center on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.
  • Rodríguez-de la Rosa L; Institute for Biomedical Research "Alberto Sols", Spanish National Research Council-Autonomous University of Madrid, Spain.
  • Contreras J; Biomedical Research Networking Center on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.
  • Sánchez-Pérez I; Institute for Biomedical Research "Alberto Sols", Spanish National Research Council-Autonomous University of Madrid, Spain.
  • Varela-Nieto I; Biomedical Research Networking Center on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.
Clin Transl Med ; 11(4): e363, 2021 04.
Article en En | MEDLINE | ID: mdl-33931965

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cisplatino / Factor Apoptótico 1 Activador de Proteasas / Pérdida Auditiva Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cisplatino / Factor Apoptótico 1 Activador de Proteasas / Pérdida Auditiva Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2021 Tipo del documento: Article